In breast cancer, previous IHC studies demonstrated that SHMT2 protein was significantly overexpressed in breast cancer tissues compared to noncancerous tissues, which correlated with increased tumour aggressiveness, including advanced TNM staging and higher Elston grade [189,190]. This evidence concerns the gene SHMT2 and neoplasm.